Bcl-2 and p53 are correlated with poor cellular differentiation, tumor progression, and lymph node metastasis (LNM), contributing to the advancement of the cancer phenotype. This evidence concerns the gene BCL2 and metastatic malignant neoplasm in the lymph nodes.